Citation: Cc. Mok et al., CRYPTOCOCCAL MENINGITIS PRESENTING CONCURRENTLY WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical and experimental rheumatology, 16(2), 1998, pp. 169-171
Citation: Cc. Mok et al., TOXICITIES OF DAPSONE IN THE TREATMENT OF CUTANEOUS MANIFESTATIONS OFRHEUMATIC DISEASES, Journal of rheumatology, 25(6), 1998, pp. 1246-1247
Citation: Cc. Mok et al., ACUTE TRANSVERSE MYELOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL PRESENTATION, TREATMENT, AND OUTCOME, Journal of rheumatology, 25(3), 1998, pp. 467-473
Authors:
MOK CC
LEU CS
HO CTK
LEE KW
MOK MY
WONG RWS
Citation: Cc. Mok et al., SAFETY OF HORMONAL REPLACEMENT THERAPY IN POSTMENOPAUSAL PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Scandinavian journal of rheumatology, 27(5), 1998, pp. 342-346
Authors:
COAKLEY G
MOK CC
HAJEER AH
OLLIER WER
TURNER D
SINNOTT PJ
HUTCHINSON IV
PANAYI GS
LANCHBURY JS
Citation: G. Coakley et al., INTERLEUKIN-10 PROMOTER POLYMORPHISMS IN RHEUMATOID-ARTHRITIS AND FELTYS-SYNDROME, British journal of rheumatology (Print), 37(9), 1998, pp. 988-991
Citation: Cc. Mok et al., RISK-FACTORS FOR AVASCULAR BONE NECROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, British journal of rheumatology (Print), 37(8), 1998, pp. 895-900
Citation: Cc. Mok et al., ARE MALES DIFFERENT FROM FEMALES IN CLINICAL MANIFESTATIONS, DISEASE COURSE AND DAMAGE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 193-193
Citation: Ctk. Ho et al., COMPARISON OF THE EFFICACY OF INTERMITTENT INTRAVENOUS PULSE AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE IN THE TREATMENT OF DIFFUSE PROLIFERATIVENEPHRITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 450-450
Citation: Cc. Mok et al., CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOME OF ADULT-ONSET STILLS-DISEASE IN SOUTHERN CHINESE, Arthritis and rheumatism, 41(9), 1998, pp. 1196-1196
Citation: Cc. Mok et al., INTERLEUKIN-10 PROMOTER POLYMORPHISMS IN SOUTHERN CHINESE PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(6), 1998, pp. 1090-1095
Citation: Cc. Mok et al., RISK-FACTORS FOR OVARIAN FAILURE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING CYCLOPHOSPHAMIDE THERAPY, Arthritis and rheumatism, 41(5), 1998, pp. 831-837
Citation: Cc. Mok et al., PROLACTIN PROFILE IN A COHORT OF CHINESE SYSTEMIC LUPUS-ERYTHEMATOSUSPATIENTS, British journal of rheumatology, 36(9), 1997, pp. 986-989
Citation: Cc. Mok et al., PHEOCHROMOCYTOMA WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME MIMICKING SEPTICEMIC SHOCK, Medical journal of Australia, 166(12), 1997, pp. 634-635
Citation: Cc. Mok et al., RISK-FACTORS FOR AVASCULAR BONE NECROSIS (AVN) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 790-790
Citation: Cs. Lau et al., REARRANGEMENT OF THE MANNOSE-BINDING LECTIN (MBL) GENE IS ASSOCIATED WITH THE DEVELOPMENT OF RHEUMATOID-ARTHRITIS (RA) IN SOUTHERN CHINESE, Arthritis and rheumatism, 40(9), 1997, pp. 1308-1308
Citation: Cc. Mok et al., ACUTE TRANSVERSE MYELOPATHY (ATM) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 1351-1351